Mobile

A Phase II open label randomized parallel group non comparative trial to assess efficacy and safety of the association of IPH1101 and IL-2 alone and in combination with dacarbazine, in patients with m...

Update Il y a 4 ans
Reference: EUCTR2007-007265-20

A Phase II open label randomized parallel group non comparative trial to assess efficacy and safety of the association of IPH1101 and IL-2 alone and in combination with dacarbazine, in patients with metastatic melanoma

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to assess the efficacy of IPH1101/IL-2 in monotherapy and in combination with Dacarbazine in advanced melanoma patients.

Inclusion criteria

  • Metastatic melanoma

Links